Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Revenues:
Total revenue	$ 978,052	$ 648,427
Costs and expenses:
Costs of research and development revenue	726,918	404,746
Research and development	810,566	1,342,862
General and administrative	1,480,040	1,655,700
Foreign currency exchange loss (gain)	11,022	(10,248)
Total costs and expenses	3,028,546	3,393,060
Loss from operations	(2,050,494)	(2,744,633)
Other income:
Interest income	104,731	2,968
Other income	989,319	250,000
Total other income	1,094,050	252,968
Net loss	$ (956,444)	$ (2,491,665)
Basic and diluted net loss per common share (in dollars per share)	$ (0.03)	$ (0.09)
Basic and diluted weighted-average common shares outstanding (in shares)	28,761,469	28,251,324
Research and Development [Member]
Revenues:
Total revenue	$ 933,934	$ 533,721
License [Member]
Revenues:
Total revenue	$ 44,118	$ 114,706